𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relationship betweenTaq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol

✍ Scribed by Mihara, Kazuo ;Suzuki, Akihito ;Kondo, Tsuyoshi ;Yasui-Furukori, Norio ;Ono, Shingo ;Otani, Koichi ;Kaneko, Sunao ;Inoue, Yoshimasa

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
65 KB
Volume
105
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No relationship betweenTaq1 a polymorphi
No relationship betweenTaq1 a polymorphism of dopamine D2 receptor gene and extrapyramidal adverse effects of selective dopamine D2 antagonists, bromperidol, and nemonapride in schizophrenia: A preliminary study
✍ Mihara, Kazuo ;Suzuki, Akihito ;Kondo, Tsuyoshi ;Nagashima, Udai ;Ono, Shingo ;O 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

The relationship between Taq1 A polymorphism of dopamine D 2 receptor (DRD 2 ) gene and extrapyramidal adverse effects of bromperidol and nemonapride, which are both antipsychotic drugs with selective and potent DRD 2 antagonistic property, was investigated in Japanese schizophrenic inpatients. Twen

The D2 dopamine receptor A1 allele and o
The D2 dopamine receptor A1 allele and opioid dependence: Association with heroin use and response to methadone treatment
✍ Lawford, Bruce R. ;Young, Ross McD. ;Noble, Ernest P. ;Sargent, Joanne ;Rowell, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

A total of 95 Caucasian opioid-dependent patients were followed over a one-year period in an outpatient methadone treatment program. The frequency of the TaqI A 1 allele of the D 2 dopamine receptor (DRD2) gene was 19.0% in these patients compared with 4.6% in controls free of past and current alcoh

Agonist and antagonist actions of yohimb
Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states
✍ Mark J. Millan; Adrian Newman-Tancredi; Valérie Audinot; Didier Cussac; François 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 1 views

Herein, we evaluate the interaction of the ␣ 2 -AR antagonist, yohimbine, as compared to fluparoxan, at multiple monoaminergic receptors and examine their roles in the modulation of adrenergic, dopaminergic and serotonergic transmission in freelymoving rats. Yohimbine displays marked affinity at hum